dihydrouracil has been researched along with Liver Neoplasms in 2 studies
hexahydropyrimidine-2,4-dione: structure in first source
5,6-dihydrouracil : A pyrimidine obtained by formal addition of hydrogen across the 5,6-position of uracil.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, BAW | 1 |
| Snoeren, N | 1 |
| Samim, M | 1 |
| Rosing, H | 1 |
| de Vries, N | 1 |
| Deenen, MJ | 1 |
| Beijnen, JH | 1 |
| Schellens, JHM | 1 |
| Koopman, M | 1 |
| van Hillegersberg, R | 1 |
| Mounier-Boutoille, H | 1 |
| Boisdron-Celle, M | 1 |
| Cauchin, E | 1 |
| Galmiche, JP | 1 |
| Morel, A | 1 |
| Gamelin, E | 1 |
| Matysiak-Budnik, T | 1 |
1 trial available for dihydrouracil and Liver Neoplasms
| Article | Year |
|---|---|
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2018 |
1 other study available for dihydrouracil and Liver Neoplasms
| Article | Year |
|---|---|
Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Dihydropyrimidine Dehydrog | 2010 |